Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Current Leases (2019 - 2025)

Historic Current Leases for Amphastar Pharmaceuticals (AMPH) over the last 7 years, with Q3 2025 value amounting to $7.8 million.

  • Amphastar Pharmaceuticals' Current Leases rose 8595.87% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year increase of 8595.87%. This contributed to the annual value of $6.8 million for FY2024, which is 7419.35% up from last year.
  • Amphastar Pharmaceuticals' Current Leases amounted to $7.8 million in Q3 2025, which was up 8595.87% from $7.9 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Current Leases registered a high of $7.9 million during Q2 2025, and its lowest value of $2.9 million during Q3 2021.
  • Its 5-year average for Current Leases is $4.3 million, with a median of $3.7 million in 2021.
  • In the last 5 years, Amphastar Pharmaceuticals' Current Leases plummeted by 2135.2% in 2021 and then soared by 9717.22% in 2025.
  • Amphastar Pharmaceuticals' Current Leases (Quarter) stood at $3.0 million in 2021, then increased by 0.7% to $3.0 million in 2022, then surged by 30.07% to $3.9 million in 2023, then surged by 74.19% to $6.8 million in 2024, then rose by 15.04% to $7.8 million in 2025.
  • Its Current Leases was $7.8 million in Q3 2025, compared to $7.9 million in Q2 2025 and $7.7 million in Q1 2025.